Evidence map›Paper›PMID 8388860›Full record

ArticleInfection and immunity1993

Mechanism of fibronectin enhancement of group B streptococcal phagocytosis by human neutrophils and culture-derived macrophages.

H R Hill, N H Augustine, P A Williams, E J Brown, J F Bohnsack

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

H R HillDepartment of Pathology and Pediatrics, University of Utah, Salt Lake City 84132.
N H Augustine
P A Williams
E J Brown
J F Bohnsack
University of Utah · US

Funding

NOVEL LYMPHOCYTE INTEGRINSR01AI024674 · NIAID · WASHINGTON UNIVERSITY · PI SHEPPARD, DEAN · 1988 to 2009
$1.7M
NOVEL LEUKOCYTE INTEGRINSR37AI024674 · NIAID · WASHINGTON UNIVERSITY · PI BROWN, ERIC J. · 1996 to 2004
$1.4M
MECHANISMS OF HOST RESISTANCE TO GROUP B STREPTOCOCCIR01AI013150 · NIAID · UNIVERSITY OF UTAH · PI HILL, HARRY R · 1985 to 1999
–
STRUCTURE/FUNCTION OF A NEUTROPHIL LAMANIN RECEPTORR29AI026733 · NIAID · UNIVERSITY OF UTAH · PI BOHNSACK, JOHN FRANCIS · 1990 to 1994
–
NIAID NIH HHS AI-13150NIAID NIH HHS AI-24674NIAID NIH HHS AI-26733
6 · The paper itself

Abstract

In previous studies, we reported that fibronectin (FN) markedly enhances phagocytic uptake of antibody-coated group B streptococci (GBS) by human polymorphonuclear leukocytes. Furthermore, administration of FN along with a GBS type-specific monoclonal or polyclonal antibody to infected neonatal rats significantly enhances survival. In this study, we have examined the molecular mechanism of this enhancement through phagocyte receptors which recognize the Arg-Gly-Asp (RGD) peptide sequences contained within the FN molecule. Incubation of human polymorphonuclear leukocytes or culture-derived macrophages on coverslips coated with GRGDSP but not GRGESP markedly enhanced uptake of immunoglobulin G-coated GBS. The enhancing effect of the RGD-containing peptides was blocked by monoclonal antibodies B6H12 (directed against the integrin-associated protein) and 7G2 (directed against the beta 3-integrin receptor for RGD). These data suggest that FN enhancement of antibody-coated GBS uptake is mediated by the critical RGD sequence. Furthermore, this active peptide sequence may have an important role in immunotherapy of bacterial infections, especially in patients with decreased plasma FN concentrations.

Indexed as

Amino Acid SequenceAntibodies, MonoclonalCells, CulturedCytochrome c GroupFibronectinsHumansMacrophagesMolecular Sequence DataNeutrophilsOligopeptidesPhagocytosisStreptococcus agalactiaeVirulence Factors, BordetellaAntibodies, Monoclonalarginyl-glycyl-aspartic acidCytochrome c GroupFibronectinsOligopeptidesVirulence Factors, Bordetella

Identifiers

PMID8388860
PMCPMC280853
OpenAlexW2294642344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.